JP2003505424A5 - - Google Patents

Download PDF

Info

Publication number
JP2003505424A5
JP2003505424A5 JP2001511942A JP2001511942A JP2003505424A5 JP 2003505424 A5 JP2003505424 A5 JP 2003505424A5 JP 2001511942 A JP2001511942 A JP 2001511942A JP 2001511942 A JP2001511942 A JP 2001511942A JP 2003505424 A5 JP2003505424 A5 JP 2003505424A5
Authority
JP
Japan
Prior art keywords
cisplatin
pharmaceutical composition
composition according
preparing
sterilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001511942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003505424A (ja
Filing date
Publication date
Priority claimed from IN535BO1999 external-priority patent/IN186588B/en
Application filed filed Critical
Publication of JP2003505424A publication Critical patent/JP2003505424A/ja
Publication of JP2003505424A5 publication Critical patent/JP2003505424A5/ja
Pending legal-status Critical Current

Links

JP2001511942A 1999-07-28 2000-07-26 非経口的シスプラチンエマルジョン Pending JP2003505424A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN535BO1999 IN186588B (enExample) 1999-07-28 1999-07-28
IN535/BOM/99 1999-07-28
PCT/IN2000/000069 WO2001007058A2 (en) 1999-07-28 2000-07-26 Parenteral cisplatin emulsion

Publications (2)

Publication Number Publication Date
JP2003505424A JP2003505424A (ja) 2003-02-12
JP2003505424A5 true JP2003505424A5 (enExample) 2005-06-09

Family

ID=11080186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001511942A Pending JP2003505424A (ja) 1999-07-28 2000-07-26 非経口的シスプラチンエマルジョン

Country Status (27)

Country Link
US (1) US6572884B1 (enExample)
EP (1) EP1204417B1 (enExample)
JP (1) JP2003505424A (enExample)
KR (1) KR20020063839A (enExample)
CN (1) CN100384436C (enExample)
AP (1) AP2002002384A0 (enExample)
AT (1) ATE269094T1 (enExample)
AU (1) AU778852B2 (enExample)
BG (1) BG106446A (enExample)
BR (1) BR0012796A (enExample)
CA (1) CA2379815A1 (enExample)
CZ (1) CZ2002268A3 (enExample)
DE (1) DE60011625T2 (enExample)
EA (1) EA004587B1 (enExample)
ES (1) ES2223571T3 (enExample)
GE (1) GEP20033046B (enExample)
HU (1) HUP0202269A3 (enExample)
IL (1) IL147786A0 (enExample)
IN (1) IN186588B (enExample)
MX (1) MXPA02002174A (enExample)
NO (1) NO20020394L (enExample)
NZ (1) NZ517502A (enExample)
PL (1) PL352577A1 (enExample)
TR (1) TR200200521T2 (enExample)
WO (1) WO2001007058A2 (enExample)
YU (1) YU13302A (enExample)
ZA (1) ZA200201548B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1459724B1 (en) * 2001-12-28 2013-11-20 Terumo Kabushiki Kaisha Blood bag system and method of inactivating pathogenic microorganisms
WO2006030450A2 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
PT1973552T (pt) * 2005-12-23 2017-07-18 Gupta Ajay Composição para nutrição parenteral contendo ferro
US20100048607A1 (en) * 2008-08-25 2010-02-25 Chandrashekhar Kocherlakota Formulations comprising palonosetron
CN102525921B (zh) * 2012-02-06 2013-08-07 西安力邦制药有限公司 2,2’,6,6’-四异丙基-4,4’-二联苯酚脂微球制剂及其制备方法
US9164954B2 (en) * 2012-10-08 2015-10-20 The Coca-Cola Company Vending accommodation and accessibility
CN104490776B (zh) * 2014-12-26 2017-06-16 本溪恒康制药有限公司 前列地尔注射液及其制备方法
CN104490777B (zh) * 2014-12-26 2019-07-23 北京蓝丹医药科技有限公司 一种丁酸氯维地平脂肪乳及其制备方法
CN110870873A (zh) * 2019-12-18 2020-03-10 吴昱晔 一种glut12蛋白抑制剂及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0647559B2 (ja) * 1990-04-04 1994-06-22 ナシヨナル・サイエンス・カウンシル 改良された安定性と徐放作用を有する標的化学療法用抗癌剤エマルジョン及びその製法
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
US6077545A (en) * 1995-10-30 2000-06-20 Matrix Pharmaceuticals, Inc. Process and composition for therapeutic cisplatin (CDDP)

Similar Documents

Publication Publication Date Title
JP5859976B2 (ja) 眼科用エマルジョン
KR100726818B1 (ko) 오일 면역 보강제 백신
KR102572389B1 (ko) 스크린 포머용의 외용 조성물
Sadeghpour et al. Bile salts caught in the act: from emulsification to nanostructural reorganization of lipid self-assemblies
PT760651E (pt) Composicoes farmaceuticas derivadas de geis a base de microemulsao, metodo para a sua preparacao e novos geis a base de microemulsao
JPS61500432A (ja) 易吸収性脂肪酸エマルシヨン
JP2003505424A5 (enExample)
JP5582635B2 (ja) プロスタグランジン含有脂肪乳剤およびその製造方法
JPS6139924B2 (enExample)
JPS62270521A (ja) フルルビプロフエン眼投与製剤
JP2001181180A (ja) 油中水型乳化組成物
EA006510B1 (ru) Фармацевтические композиции на основе производных азетидина
JP4929158B2 (ja) 難水溶性薬物を含有する医薬組成物
AU778852B2 (en) Parenteral cisplatin emulsion
JP4228435B2 (ja) 粉末油脂組成物およびその製造方法
JP2003342171A5 (enExample)
JP2828655B2 (ja) 脂溶性薬物含有水性液
JPH06511419A (ja) ミクロエマルジョンを製造する方法
JP2002003339A (ja) 多層型組成物
CN102911788A (zh) 一种水溶性茶树油及其制备方法
JP5105663B2 (ja) 塩化リゾチームを含む粘性化粧料又は薬剤の製造方法並びに塩化リゾチームを含む粘性化粧料又は薬剤
JPS59210025A (ja) 中鎖トリグリセリドの乳化組成物の製法
JPS6014933A (ja) 水中油型エマルシヨンの製造方法
JPS62221629A (ja) リン脂質乳剤の製造方法
JPS62225240A (ja) 多価アルコ−ル中油型乳化組成物